Literature DB >> 21326514

Preoperative portal venous and hepatic arterial embolization of tumor.

Eric M Walser1.   

Abstract

Although the goal of embolization is usually to create therapeutic ischemia or hemostasis without surgery, the rationale for preoperative embolotherapy is different in several respects. First, the aim is to prepare patients for definitive surgical resection rather than cure or palliation, and, thus, the goals and expectations are limited and defined by close communication between the interventionalist and the surgeon. Second, when considering segmental resection, the normal liver should be protected from procedural damage. Third, the search for extrahepatic disease is crucial for these patients because resection is typically abandoned in favor of alternative therapies for patients with systemic disease. Finally, intraoperative ultrasound should always be considered to survey the future liver remnant for unsuspected small tumors and allow ablation of these lesions to maximize the success of partial hepatectomy. This article describes preoperative hepatic arterial and portal venous embolization in patients with or without cirrhosis complicated by tumors judged eligible for surgical resection or orthotopic liver transplantation (OLT). Each type of embolization will be reviewed in terms of indications and contraindications, technique, and complications. Finally, the outcomes will be evaluated in terms of morbidity, mortality, and tumor recurrence rates.

Entities:  

Keywords:  Liver surgery; liver cancer; liver metastases; portal vein embolization; transcatheter arterial chemoembolization

Year:  2008        PMID: 21326514      PMCID: PMC3036443          DOI: 10.1055/s-0028-1085926

Source DB:  PubMed          Journal:  Semin Intervent Radiol        ISSN: 0739-9529            Impact factor:   1.513


  50 in total

1.  Preoperative hepatic artery chemoembolization followed by orthotopic liver transplantation for hepatocellular carcinoma.

Authors:  D M Harnois; J Steers; J C Andrews; J C Rubin; H C Pitot; L Burgart; R H Wiesner; G J Gores
Journal:  Liver Transpl Surg       Date:  1999-05

2.  Preoperative portal vein embolization improves prognosis after right hepatectomy for hepatocellular carcinoma in patients with impaired hepatic function.

Authors:  H Tanaka; K Hirohashi; S Kubo; T Shuto; I Higaki; H Kinoshita
Journal:  Br J Surg       Date:  2000-07       Impact factor: 6.939

3.  Transcatheter arterial chemoembolization of liver tumors: effects of embolization protocol on injectable volume of chemotherapy and subsequent arterial patency.

Authors:  Jean-Francois H Geschwind; Douglas E Ramsey; Berry Cleffken; B C H van der Wal; Hicham Kobeiter; Krishna Juluru; George G Hartnell; Michael A Choti
Journal:  Cardiovasc Intervent Radiol       Date:  2003-03-06       Impact factor: 2.740

4.  Indications for portal vein embolization combined with major hepatic resection for advanced-stage hepatocellular carcinomas. A preliminary clinical study.

Authors:  H Wakabayashi; S Yachida; T Maeba; H Maeta
Journal:  Dig Surg       Date:  2000       Impact factor: 2.588

5.  Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization.

Authors:  D Azoulay; D Castaing; A Smail; R Adam; V Cailliez; A Laurent; A Lemoine; H Bismuth
Journal:  Ann Surg       Date:  2000-04       Impact factor: 12.969

6.  Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation.

Authors:  J M Llovet; J Fuster; J Bruix
Journal:  Hepatology       Date:  1999-12       Impact factor: 17.425

7.  Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimeters.

Authors:  Sasan Roayaie; Jason S Frischer; Sukru H Emre; Thomas M Fishbein; Patricia A Sheiner; Max Sung; Charles M Miller; Myron E Schwartz
Journal:  Ann Surg       Date:  2002-04       Impact factor: 12.969

Review 8.  Sequential transarterial chemoembolization for unresectable advanced hepatocellular carcinoma.

Authors:  H J Jaeger; U M Mehring; F Castañeda; F Hasse; G Blumhardt; D Loehlein; K D Mathias
Journal:  Cardiovasc Intervent Radiol       Date:  1996 Nov-Dec       Impact factor: 2.740

9.  Risk of major liver resection in patients with underlying chronic liver disease: a reappraisal.

Authors:  O Farges; B Malassagne; J F Flejou; S Balzan; A Sauvanet; J Belghiti
Journal:  Ann Surg       Date:  1999-02       Impact factor: 12.969

10.  Portal vein embolization before right hepatectomy: prospective clinical trial.

Authors:  Olivier Farges; Jacques Belghiti; Reza Kianmanesh; Jean Marc Regimbeau; Roberto Santoro; Valérie Vilgrain; Alban Denys; Alain Sauvanet
Journal:  Ann Surg       Date:  2003-02       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.